FUNCTION PROMOTING THERAPIES, LLC

Digital health · Private

TruT algorithm—a computational method that calculates free testosterone concentrations from blood biomarkers, validated across sex, hormone levels, and gender-affirming therapy populations

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Digital health
Total capital: $4M

Federal grants: $4M; 4 awards · 2017–2023; Sector median 0 awards
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 6 pending · first 2019

Capital timeline

Latest events

Aug 2023Federal grantHealth and Human S · Phase II · Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders$949K
Sep 2022Federal grantHealth and Human S · Phase II · Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders$1M
Jun 2018Federal grantHealth and Human S · Phase II · Phase II: Research and Commercialization of TruT Algorithm for Free Testosterone$975K
Sep 2017Federal grantHealth and Human S · Phase II · Phase II: Research and Commercialization of TruT Algorithm for Free Testosterone$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing in Digital health · 818 companies

Line = median

Federal contracts#51 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 7

Jun 30, 2022PendingMethods And Systems For The Diagnosis And Treatment Of Sex Hormone DisordersUSPTOApplication 17497652
Jun 4, 2020PendingMethods And Systems For The Diagnosis And Treatment Of Androgen DisordersUSPTOApplication 16503286
Aug 20, 2019GrantedMethods And Systems For The Diagnosis And Treatment Of Androgen DisordersUSPTOUS 10,386,375

Show all 7 patent records

Methods And Systems For The Diagnosis And Treatment Of Sex Hormone DisordersJun 30, 2022 · Application 17497652Pending
Methods And Systems For The Diagnosis And Treatment Of Androgen DisordersJun 4, 2020 · Application 16503286Pending
Methods And Systems For The Diagnosis And Treatment Of Androgen DisordersAug 20, 2019 · US 10,386,375Granted
Combination Of Testosterone And Ornithine Decarboxylase (odc) InhibitorsJul 11, 2013 · Application 13679889Pending
Methods And Systems For The Diagnosis And Treatment Of Sex Hormone DisordersApplication 63090115Pending
Methods And Systems For The Diagnosis And Treatment Of Androgen DisordersApplication PCTUS2014020223Pending
Method For Determination Of Free Sex Steroid ConcentrationApplication 61772054Pending

Recent research by its founders

Multiple Dynamically-Coupled Binding Sites on Human Serum Albumin Regulate Estradiol's Nonlinear Binding20261 cites
Abstract 3175: Comparative efficacy of MUC1-C (XYA02) and MUC1-N (PankoMab, DS-3939a analog) antibody-drug conjugates in preclinical NSCLC20260 cites
Abstract 4539: A MUC1-C-targeting ADC exhibits potent antitumor activity against neuroendocrine prostate cancer in both intact and testosterone-depleted preclinical models20260 cites

COGNIVIVE, INC.Similar federal contract value in Digital health · null in contracts
SANICKA, INCSimilar federal contract value in Digital health · null in contracts
PERCEPTION DYNAMICS INSTITUTESimilar federal contract value in Digital health · null in contracts
ALGORITHMRX, LLCSimilar federal contract value in Digital health · null in contracts
PARADOCS HEALTH INC.Similar federal contract value in Digital health · null in contracts
Daynamica Inc.Similar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.